Breaking News Instant updates and real-time market news.

DCT

Duck Creek Technologies

$36.70 /

-0.47 (-1.26%)

08:09
09/08/20
09/08
08:09
09/08/20
08:09

Duck Creek Technologies initiated with a Buy at Needham

Needham analyst Mayank Tandon initiated coverage of Duck Creek Technologies with a Buy rating and $47 price target. The analyst is positive on the company's "impressive" pace of subscription revenue growth, premium professional services margins, and potential for long-term margin expansion, which warrant its premium valuation. Tandon further cites Duck Creek's "strong" competitive positioning and accelerating revenue growth, adding that the P&C insurance industry is a large market that is in the early days of transitioning towards the cloud.

  • 14

    Aug

DCT Duck Creek Technologies
$36.70 /

-0.47 (-1.26%)

09/08/20 JPMorgan
Duck Creek Technologies initiated with a Neutral at JPMorgan
09/08/20 Raymond James
Duck Creek Technologies initiated with an Outperform at Raymond James
09/08/20 William Blair
Duck Creek Technologies initiated with an Outperform at William Blair
09/08/20 Barclays
Duck Creek Technologies initiated with an Equal Weight at Barclays

TODAY'S FREE FLY STORIES

General news
Asian Market Update: » 01:40
09/25/20
09/25
01:40
09/25/20
01:40

Asian Market Update:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Scorpio Tankers financing activity to increase liquidity by $82M » 22:53
09/24/20
09/24
22:53
09/24/20
22:53
STNG

Scorpio Tankers

$10.74 /

+0.005 (+0.05%)

Scorpio Tankers announced…

Scorpio Tankers announced an update on financing facilities, which are expected to increase liquidity by approximately $82.0M. The company has finalized commitments from three financial institutions for the sale and leaseback of eight MR product tankers that were previously mentioned and has received a new commitment for a scrubber financing facility. Two of the eight vessels have already been delivered to their buyer, and the remaining six vessels are expected to be delivered to their buyers in the fourth quarter of 2020. Upon completion of all the transactions for the eight vessels and the repayment of their existing debt, the Company expects to have raised approximately $70Mof liquidity in aggregate. In addition, the company has received a new commitment of $12.0M to finance scrubbers on six MRs of which, five have been installed to date. Including this new financing arrangement, the company expects to raise approximately $66M of aggregate additional liquidity once all of the previously announced scrubber financing agreements are closed and drawn.

ShowHide Related Items >><<
STNG Scorpio Tankers
$10.74 /

+0.005 (+0.05%)

STNG Scorpio Tankers
$10.74 /

+0.005 (+0.05%)

07/28/20 Deutsche Bank
Scorpio Tankers price target lowered to $27 from $42 at Deutsche Bank
06/19/20 B. Riley FBR
Scorpio Tankers price target lowered to $45 from $55 at B. Riley FBR
06/04/20 Pareto
Scorpio Tankers downgraded to Hold from Buy at Pareto
06/02/20 Fearnley
Scorpio Tankers downgraded to Sell from Hold at Fearnley
STNG Scorpio Tankers
$10.74 /

+0.005 (+0.05%)

STNG Scorpio Tankers
$10.74 /

+0.005 (+0.05%)

Syndicate
Prelude Therapeutics 8.325M share IPO priced at $19.00 » 21:55
09/24/20
09/24
21:55
09/24/20
21:55
PRLD

Prelude Therapeutics

$0.00 /

+ (+0.00%)

The deal priced at the…

The deal priced at the high-end of the $17.00-$19.00 range. Morgan Stanley, Goldman Sachs and BofA acted as joint book running managers for the offering.

ShowHide Related Items >><<
  • 25
    Sep
Syndicate
Penn National 14M share Secondary priced at $61.00 » 21:52
09/24/20
09/24
21:52
09/24/20
21:52
PENN

Penn National

$64.05 /

-5.05 (-7.31%)

Goldman Sachs, BofA and…

Goldman Sachs, BofA and JPMorgan acted as joint book running managers for the offering.

ShowHide Related Items >><<
PENN Penn National
$64.05 /

-5.05 (-7.31%)

PENN Penn National
$64.05 /

-5.05 (-7.31%)

09/24/20
Fly Intel: Top five analyst downgrades
09/24/20 Truist
Truist raises price targets on select Gaming names
09/24/20 Macquarie
Penn National downgraded to Neutral from Outperform at Macquarie
09/24/20 Macquarie
Penn National downgraded to Neutral from Outperform at Macquarie
PENN Penn National
$64.05 /

-5.05 (-7.31%)

  • 25
    Sep
  • 12
    May
PENN Penn National
$64.05 /

-5.05 (-7.31%)

PENN Penn National
$64.05 /

-5.05 (-7.31%)

PENN Penn National
$64.05 /

-5.05 (-7.31%)

Syndicate
Graybug Vision 5.625M share IPO priced at $16.00 » 20:46
09/24/20
09/24
20:46
09/24/20
20:46
GRAY

Graybug Vision

$0.00 /

+ (+0.00%)

The deal size was…

The deal size was increased to 5.625M shares from 4.689M and priced at the midpoint of target $15.00-$17.00 range. SVB Leerink and Piper Sandler acted as joint book running managers for the offering.

ShowHide Related Items >><<
  • 25
    Sep
GRAY Graybug Vision
$0.00 /

+ (+0.00%)

Syndicate
PMV Pharmaceuticals 11.765M share IPO priced at $18.00 » 20:20
09/24/20
09/24
20:20
09/24/20
20:20
PMVP

PMV Pharmaceuticals

$0.00 /

+ (+0.00%)

The deal size was…

The deal size was increased to 11.765M shares from 7.35M and priced at high end of $16.00-$18.00 target range. Goldman Sachs, BofA, Cowen and Evercore ISI are acting as joint book running managers for the offering.

ShowHide Related Items >><<
  • 25
    Sep
Hot Stocks
American Campus CEO sells 120K shares of common stock » 20:11
09/24/20
09/24
20:11
09/24/20
20:11
ACC

American Campus

$33.55 /

+0.49 (+1.48%)

In a regulatory filing,…

In a regulatory filing, American Campus disclosed that its CEO William Bayless sold 15K shares of common stock on September 22nd in a total transaction size of $4.2M. The holding represents about 28% of his total owned.

ShowHide Related Items >><<
ACC American Campus
$33.55 /

+0.49 (+1.48%)

ACC American Campus
$33.55 /

+0.49 (+1.48%)

09/21/20 Piper Sandler
American Campus downgraded to Neutral from Overweight at Piper Sandler
08/20/20 JPMorgan
College closings create downside risk for American Campus, says JPMorgan
07/27/20 KeyBanc
American Campus price target lowered to $40 from $45 at KeyBanc
04/20/20 KeyBanc
American Campus price target lowered to $45 from $51 at KeyBanc
ACC American Campus
$33.55 /

+0.49 (+1.48%)

ACC American Campus
$33.55 /

+0.49 (+1.48%)

Hot Stocks
Schrodinger director institutional holder DE Shaw sells 454K shares » 20:10
09/24/20
09/24
20:10
09/24/20
20:10
SDGR

Schrodinger

$46.83 /

-2.68 (-5.41%)

In a regulatory filing,…

In a regulatory filing, Schrodinger disclosed that David E Shaw sold 453.9K shares on September 22nd in a total transaction size of $22.6M.

ShowHide Related Items >><<
SDGR Schrodinger
$46.83 /

-2.68 (-5.41%)

SDGR Schrodinger
$46.83 /

-2.68 (-5.41%)

08/10/20
Schrodinger files to sell 4.5M shares of common stock
06/02/20 BMO Capital
Schrodinger price target raised to $85 from $67 at BMO Capital
03/02/20
Fly Intel: Top five analyst initiations
03/02/20 Jefferies
Schrodinger initiated with a Hold at Jefferies
SDGR Schrodinger
$46.83 /

-2.68 (-5.41%)

  • 13
    Aug
  • 06
    Feb
SDGR Schrodinger
$46.83 /

-2.68 (-5.41%)

Syndicate
Greenwich LifeSciences 1.26M share IPO priced at $5.75 » 20:01
09/24/20
09/24
20:01
09/24/20
20:01
GLSI

Greenwich LifeSciences

$0.00 /

+ (+0.00%)

Aegis is acting as sole…

Aegis is acting as sole book running manager for the offering.

Periodicals
Palantir to debut around $10 per share, WSJ says » 19:52
09/24/20
09/24
19:52
09/24/20
19:52
PLTR

Palantir

$0.00 /

+ (+0.00%)

Ahead of its September…

Ahead of its September 30th debut, Palantir Technologies is expected to start trading around $10 per share, implying valuation of nearly $22B, The Wall Street Journals Maureen Farrell, Corrie Driebusch and Eliot Brown report, citing people familiar with the matter. The report notes that the company is going public through a direct listing rather than through a traditional IPO route. Reference Link

ShowHide Related Items >><<
PLTR Palantir
$0.00 /

+ (+0.00%)

PLTR Palantir
$0.00 /

+ (+0.00%)

Periodicals
Pac-12 to play seven-game college football season starting Nov. 6, ESPN says » 19:19
09/24/20
09/24
19:19
09/24/20
19:19
PENN

Penn National

$64.05 /

-5.05 (-7.31%)

, MGM

MGM Resorts

$21.20 /

-0.185 (-0.87%)

, LVS

Las Vegas Sands

$45.90 /

+0.88 (+1.95%)

, GAN

Gan Limited

$15.10 /

-0.02 (-0.13%)

, PDYPY

Flutter Entertainment

$0.00 /

+ (+0.00%)

, DKNG

DraftKings

$50.58 /

+0.48 (+0.96%)

, CHDN

Churchill Downs

$148.41 /

-16.01 (-9.74%)

, CZR

Caesars

$52.79 /

-1.98 (-3.62%)

, BYD

Boyd Gaming

$28.18 /

+0.49 (+1.77%)

, WIMHY

William Hill

$0.00 /

+ (+0.00%)

, WYNN

Wynn Resorts

$71.04 /

+0.39 (+0.55%)

The Pac-12 intends to…

The Pac-12 intends to play a seven-game college football season starting November 6, ESPN's Heather Dinich reports, citing a source. Publicly traded companies in the sports betting space include Boyd Gaming (BYD), Caesars (CZR), Churchill Downs (CHDN), DraftKings (DKNG), Flutter Entertainment (PDYPY), Gan Limited (GAN), Las Vegas Sands (LVS), MGM Resorts (MGM), Penn National (PENN), William Hill (WIMHY) and Wynn Resorts (WYNN). Reference Link

ShowHide Related Items >><<
WYNN Wynn Resorts
$71.04 /

+0.39 (+0.55%)

WIMHY William Hill
$0.00 /

+ (+0.00%)

PENN Penn National
$64.05 /

-5.05 (-7.31%)

MGM MGM Resorts
$21.20 /

-0.185 (-0.87%)

LVS Las Vegas Sands
$45.90 /

+0.88 (+1.95%)

GAN Gan Limited
$15.10 /

-0.02 (-0.13%)

DKNG DraftKings
$50.58 /

+0.48 (+0.96%)

CZR Caesars
$52.79 /

-1.98 (-3.62%)

CHDN Churchill Downs
$148.41 /

-16.01 (-9.74%)

BYD Boyd Gaming
$28.18 /

+0.49 (+1.77%)

PENN Penn National
$64.05 /

-5.05 (-7.31%)

09/24/20
Fly Intel: Top five analyst downgrades
09/24/20 Truist
Truist raises price targets on select Gaming names
09/24/20 Macquarie
Penn National downgraded to Neutral from Outperform at Macquarie
09/24/20 Macquarie
Penn National downgraded to Neutral from Outperform at Macquarie
MGM MGM Resorts
$21.20 /

-0.185 (-0.87%)

09/24/20 Macquarie
MGM Resorts price target raised to $30 from $27 at Macquarie
09/16/20
Fly Intel: Top five analyst downgrades
09/16/20 Roth Capital
MGM Resorts downgraded to Neutral from Buy at Roth Capital
LVS Las Vegas Sands
$45.90 /

+0.88 (+1.95%)

09/16/20 Roth Capital
Las Vegas Sands downgraded to Neutral from Buy at Roth Capital
09/16/20 Roth Capital
Wynn Resorts downgraded to Neutral from Buy at Roth Capital
09/10/20 Deutsche Bank
Las Vegas Sands price target raised to $60 from $54 at Deutsche Bank
GAN Gan Limited
$15.10 /

-0.02 (-0.13%)

08/21/20 B. Riley FBR
Gan selloff on FanDuel loss an overreaction, says B. Riley FBR
08/21/20 Craig-Hallum
Craig-Hallum says FanDuel migration a 'temporary blip' for Gan Limited
08/17/20 B. Riley FBR
DraftKings iGaming results positive for Gan Limited, says B. Riley FBR
08/12/20 Craig-Hallum
NJ sports betting up, iGaming revenue still strong, says Craig-Hallum
PDYPY Flutter Entertainment
$0.00 /

+ (+0.00%)

09/22/20 Morgan Stanley
Barstool Sportsbook app 'bullish' for the sector, says Morgan Stanley
09/15/20 Oppenheimer
DraftKings price target raised to $55 from $50 at Oppenheimer
09/14/20 Deutsche Bank
Flutter price target raised to 11,800 GBp from 10,200 GBp at Deutsche Bank
09/08/20 Barclays
Flutter Entertainment upgraded to Overweight from Equal Weight at Barclays
DKNG DraftKings
$50.58 /

+0.48 (+0.96%)

09/24/20
Fly Intel: Top five analyst initiations
09/24/20 Macquarie
DraftKings initiated with an Outperform at Macquarie
09/24/20 Macquarie
DraftKings initiated with an Outperform at Macquarie
CHDN Churchill Downs
$148.41 /

-16.01 (-9.74%)

09/10/20
Fly Intel: Top five analyst downgrades
09/10/20 Jefferies
Jefferies cuts Churchill Downs to Hold after outperformance, ups target to $191
09/10/20 Jefferies
Churchill Downs downgraded to Hold from Buy at Jefferies
08/24/20 Susquehanna
Churchill Downs downgraded to Neutral from Positive at Susquehanna
CZR Caesars
$52.79 /

-1.98 (-3.62%)

09/22/20 Roth Capital
Caesars value creation of $38/share through spinoff likely this year, says Roth
09/22/20 Deutsche Bank
Caesars price target raised to $65 from $50 at Deutsche Bank
BYD Boyd Gaming
$28.18 /

+0.49 (+1.77%)

09/24/20 Macquarie
Boyd Gaming price target raised to $35 from $33 at Macquarie
09/09/20 JPMorgan
Boyd Gaming price target raised to $40 from $30 at JPMorgan
08/28/20 Union Gaming
Boyd Gaming upgraded to Buy from Hold at Union Gaming
WIMHY William Hill
$0.00 /

+ (+0.00%)

09/14/20 Jefferies
William Hill shares haven't priced in building U.S. momentum, says Jefferies
09/10/20 Berenberg
William Hill price target raised to 200 GBp from 150 GBp at Berenberg
09/09/20 Morgan Stanley
William Hill price target raised to 230 GBp from 200 GBp at Morgan Stanley
09/08/20 Barclays
William Hill price target raised to 240 GBp from 200 GBp at Barclays
WYNN Wynn Resorts
$71.04 /

+0.39 (+0.55%)

09/10/20 Deutsche Bank
Wynn Resorts price target raised to $97 from $89 at Deutsche Bank
09/09/20 JPMorgan
Wynn Resorts price target raised to $101 from $98 at JPMorgan
09/06/20 Goldman Sachs
Wynn Resorts downgraded to Neutral from Conviction Buy at Goldman Sachs
WYNN Wynn Resorts
$71.04 /

+0.39 (+0.55%)

PENN Penn National
$64.05 /

-5.05 (-7.31%)

MGM MGM Resorts
$21.20 /

-0.185 (-0.87%)

LVS Las Vegas Sands
$45.90 /

+0.88 (+1.95%)

GAN Gan Limited
$15.10 /

-0.02 (-0.13%)

DKNG DraftKings
$50.58 /

+0.48 (+0.96%)

CZR Caesars
$52.79 /

-1.98 (-3.62%)

CHDN Churchill Downs
$148.41 /

-16.01 (-9.74%)

BYD Boyd Gaming
$28.18 /

+0.49 (+1.77%)

  • 25
    Sep
  • 19
    Jun
  • 12
    May
  • 05
    May
PENN Penn National
$64.05 /

-5.05 (-7.31%)

MGM MGM Resorts
$21.20 /

-0.185 (-0.87%)

LVS Las Vegas Sands
$45.90 /

+0.88 (+1.95%)

GAN Gan Limited
$15.10 /

-0.02 (-0.13%)

CZR Caesars
$52.79 /

-1.98 (-3.62%)

WYNN Wynn Resorts
$71.04 /

+0.39 (+0.55%)

PENN Penn National
$64.05 /

-5.05 (-7.31%)

MGM MGM Resorts
$21.20 /

-0.185 (-0.87%)

LVS Las Vegas Sands
$45.90 /

+0.88 (+1.95%)

GAN Gan Limited
$15.10 /

-0.02 (-0.13%)

DKNG DraftKings
$50.58 /

+0.48 (+0.96%)

CZR Caesars
$52.79 /

-1.98 (-3.62%)

BYD Boyd Gaming
$28.18 /

+0.49 (+1.77%)

WYNN Wynn Resorts
$71.04 /

+0.39 (+0.55%)

PENN Penn National
$64.05 /

-5.05 (-7.31%)

MGM MGM Resorts
$21.20 /

-0.185 (-0.87%)

LVS Las Vegas Sands
$45.90 /

+0.88 (+1.95%)

GAN Gan Limited
$15.10 /

-0.02 (-0.13%)

DKNG DraftKings
$50.58 /

+0.48 (+0.96%)

CZR Caesars
$52.79 /

-1.98 (-3.62%)

BYD Boyd Gaming
$28.18 /

+0.49 (+1.77%)

Hot Stocks
American Campus CEO sells 120,000 common shares » 19:03
09/24/20
09/24
19:03
09/24/20
19:03
ACC

American Campus

$33.55 /

+0.49 (+1.48%)

In a regulatory filing,…

In a regulatory filing, American Campus Communities CEO William C. Bayless, Jr. disclosed the sale of 120,000 common shares of the company on September 22 at a price of $35.12 per share.

ShowHide Related Items >><<
ACC American Campus
$33.55 /

+0.49 (+1.48%)

ACC American Campus
$33.55 /

+0.49 (+1.48%)

09/21/20 Piper Sandler
American Campus downgraded to Neutral from Overweight at Piper Sandler
08/20/20 JPMorgan
College closings create downside risk for American Campus, says JPMorgan
07/27/20 KeyBanc
American Campus price target lowered to $40 from $45 at KeyBanc
04/20/20 KeyBanc
American Campus price target lowered to $45 from $51 at KeyBanc
ACC American Campus
$33.55 /

+0.49 (+1.48%)

ACC American Campus
$33.55 /

+0.49 (+1.48%)

Periodicals
Tyler says cyberattack against it used ransomware, Reuters reports » 19:02
09/24/20
09/24
19:02
09/24/20
19:02
AMZN

Amazon.com

$3,019.70 /

+21.05 (+0.70%)

, TYL

Tyler Technologies

$334.25 /

-4.28 (-1.26%)

Tyler Technologies (TYL)…

Tyler Technologies (TYL) said that the cyberattack against the company disclosed earlier this week used ransomware, which encrypts company files and demands payment to decrypt them again, Reuters' Joseph Menn reports. The company told Reuters that attacker only access internal networks, adding that the hack had no impact on the software it hosts for clients. Tyler added that the software it sells that displays election results is hosted by Amazon (AMZN) and therefore was not at risk, Menn notes. "We have confirmed that the malicious software the intruder used was ransomware. Because this is an active investigation, we will not provide any additional specifics relating to our incident response or our investigation at this time," Tyler said. Reference Link

ShowHide Related Items >><<
TYL Tyler Technologies
$334.25 /

-4.28 (-1.26%)

AMZN Amazon.com
$3,019.70 /

+21.05 (+0.70%)

AMZN Amazon.com
$3,019.70 /

+21.05 (+0.70%)

09/24/20 Piper Sandler
Amazon.com assumed with an Overweight at Piper Sandler
09/24/20 Morgan Stanley
Alphabet price target raised to $1,800 after consumer survey at Morgan Stanley
09/23/20 Piper Sandler
Amazon Care program expansion not a threat to Teladoc, says Piper Sandler
09/23/20 Benchmark
Benchmark says Microsoft partnership can be 'big driver' for Kratos
TYL Tyler Technologies
$334.25 /

-4.28 (-1.26%)

09/22/20 Baird
Baird upgrades Tyler Technologies to Outperform on post-COVID opportunity
09/22/20 Baird
Tyler Technologies upgraded to Outperform from Neutral at Baird
07/31/20 Northland
Tyler Technologies price target raised to $400 from $350 at Northland
07/28/20
Fly Intel: Top five analyst downgrades
TYL Tyler Technologies
$334.25 /

-4.28 (-1.26%)

AMZN Amazon.com
$3,019.70 /

+21.05 (+0.70%)

AMZN Amazon.com
$3,019.70 /

+21.05 (+0.70%)

AMZN Amazon.com
$3,019.70 /

+21.05 (+0.70%)

AMZN Amazon.com
$3,019.70 /

+21.05 (+0.70%)

AMZN Amazon.com
$3,019.70 /

+21.05 (+0.70%)

Conference/Events
Albemarle participates in a conference call with UBS » 18:55
09/24/20
09/24
18:55
09/24/20
18:55
ALB

Albemarle

$83.17 /

+2.8 (+3.48%)

Global Head of Mining…

Global Head of Mining Research Lawcock and North American Chemical Equity Research Director Roberts holds a conference call with management on September 24 at 7 pm hosted by UBS. Webcast Link

ShowHide Related Items >><<
ALB Albemarle
$83.17 /

+2.8 (+3.48%)

ALB Albemarle
$83.17 /

+2.8 (+3.48%)

09/23/20 Raymond James
Market overreacting to Musk's lithium comments, says Raymond James
09/23/20 Morgan Stanley
Morgan Stanley says Tesla battery technologies 'bearish for lithium'
09/23/20 Baird
Albemarle designated as a bearish Fresh Pick at Baird
09/22/20 Evercore ISI
Albemarle initiated with an Underperform at Evercore ISI
ALB Albemarle
$83.17 /

+2.8 (+3.48%)

ALB Albemarle
$83.17 /

+2.8 (+3.48%)

ALB Albemarle
$83.17 /

+2.8 (+3.48%)

ALB Albemarle
$83.17 /

+2.8 (+3.48%)

On The Fly
Fly Intel: After-Hours Movers » 18:48
09/24/20
09/24
18:48
09/24/20
18:48
JRJC

China Finance Online

$7.48 /

-0.27 (-3.48%)

, AIR

AAR Corp.

$17.84 /

+0.36 (+2.06%)

, CAMP

CalAmp

$7.90 /

-0.14 (-1.74%)

, MTN

Vail Resorts

$224.35 /

-3.98 (-1.74%)

, CLNY

Colony Capital

$2.34 /

-0.03 (-1.27%)

, GNFT

Genfit

$3.67 /

-0.28 (-7.09%)

, ALT

Altimmune

$12.03 /

-0.5 (-3.99%)

, NVAX

Novavax

$102.48 /

+0.92 (+0.91%)

, SAVA

Cassava Sciences

$9.72 /

-0.065 (-0.66%)

, BMY

Bristol-Myers

$58.24 /

-0.76 (-1.29%)

, IBEX

Ibex

$10.95 /

+0.7 (+6.83%)

, COST

Costco

$347.25 /

+2.67 (+0.77%)

Check out this evening's…

ShowHide Related Items >><<
SAVA Cassava Sciences
$9.72 /

-0.065 (-0.66%)

NVAX Novavax
$102.48 /

+0.92 (+0.91%)

MTN Vail Resorts
$224.35 /

-3.98 (-1.74%)

JRJC China Finance Online
$7.48 /

-0.27 (-3.48%)

IBEX Ibex
$10.95 /

+0.7 (+6.83%)

GNFT Genfit
$3.67 /

-0.28 (-7.09%)

COST Costco
$347.25 /

+2.67 (+0.77%)

CLNY Colony Capital
$2.34 /

-0.03 (-1.27%)

CAMP CalAmp
$7.90 /

-0.14 (-1.74%)

BMY Bristol-Myers
$58.24 /

-0.76 (-1.29%)

ALT Altimmune
$12.03 /

-0.5 (-3.99%)

AIR AAR Corp.
$17.84 /

+0.36 (+2.06%)

JRJC China Finance Online
$7.48 /

-0.27 (-3.48%)

AIR AAR Corp.
$17.84 /

+0.36 (+2.06%)

07/15/20 Truist
SunTrust downgrades select commercial aviation supply stocks
07/15/20 Truist
AAR Corp. downgraded to Hold from Buy at SunTrust
06/30/20 Canaccord
AAR Corp. upcoming results focused on second half recovery, says Canaccord
03/18/20 Canaccord
AAR Corp. price target lowered to $25 from $55 at Canaccord
CAMP CalAmp
$7.90 /

-0.14 (-1.74%)

04/17/20 Jefferies
CalAmp upgraded to Buy at Jefferies with downside case seen as priced in
04/17/20 Jefferies
CalAmp upgraded to Buy from Hold at Jefferies
03/26/20 JPMorgan
CalAmp price target lowered to $9 from $12 at JPMorgan
03/06/20 Canaccord
CalAmp price target lowered to $12 from $17 at Canaccord
MTN Vail Resorts
$224.35 /

-3.98 (-1.74%)

09/11/20 Deutsche Bank
Vail Resorts price target raised to $204 from $174 at Deutsche Bank
08/31/20
Fly Intel: Top five analyst downgrades
08/31/20 KeyBanc
KeyBanc downgrades Vail Resorts on concerns over resort model
08/31/20 KeyBanc
Vail Resorts downgraded to Sector Weight from Overweight at KeyBanc
CLNY Colony Capital
$2.34 /

-0.03 (-1.27%)

06/04/20 B. Riley FBR
Colony Capital price target lowered to $4 from $5 at B. Riley FBR
03/11/20 B. Riley FBR
B. Riley FBR downgrades CNO Financial, Progressive to Neutral from Buy
GNFT Genfit
$3.67 /

-0.28 (-7.09%)

08/05/20 H.C. Wainwright
Lancet publication 'strong validation' Genfit's NIS4, says H.C. Wainwright
07/23/20 H.C. Wainwright
Genfit price target lowered to $8 from $11 at H.C. Wainwright
07/23/20
Fly Intel: Top five analyst upgrades
07/23/20 Stifel
Genfit upgraded to Buy from Hold at Stifel
ALT Altimmune
$12.03 /

-0.5 (-3.99%)

09/22/20 Piper Sandler
Altimmune nearing two 'key stock-moving events,' says Piper Sandler
09/09/20 Piper Sandler
Piper sees 'no readthrough' to Altimmune from AstraZeneca COVID trial hold
08/25/20 Piper Sandler
Altimmune a 'stand out' from other COVID vaccine makers, says Piper Sandler
08/25/20 JMP Securities
Altimmune's AdCOVID to have 'unique advantages' over other vaccines, says JMP
NVAX Novavax
$102.48 /

+0.92 (+0.91%)

09/15/20 B. Riley FBR
Novavax deal with SIIPL doubles manufacturing capacity, says B. Riley FBR
09/09/20 B. Riley FBR
Astra trial hold opens window for other vaccine candidates, says B. Riley FBR
09/08/20 B. Riley FBR
Novavax selloff brings 'compelling' buying opportunity, says B. Riley FBR
09/03/20 Cantor Fitzgerald
Cantor says Novavax publication in NEJM gives 'validation' for vaccine candidate
SAVA Cassava Sciences
$9.72 /

-0.065 (-0.66%)

09/23/20 H.C. Wainwright
Cassava Sciences upgraded to Buy from Neutral at H.C. Wainwright
09/14/20 Maxim
Cassava upgraded to Buy at Maxim after second analysis of AD drug data
09/14/20 Maxim
Cassava Sciences upgraded to Buy from Hold at Maxim
05/18/20 H.C. Wainwright
Cassava Sciences downgraded to Neutral from Buy at H.C. Wainwright
BMY Bristol-Myers
$58.24 /

-0.76 (-1.29%)

09/22/20 Oppenheimer
Bluebird Bio review timeline consistent with expectations, says Oppenheimer
08/25/20 Piper Sandler
Bristol's trial miss has 'no financial impact' on Agios, says Piper Sandler
08/06/20 Citi
Investors can refocus on Bristol-Myers story after Eliquis win, says Citi
07/28/20 Mizuho
Wait for Bristol-Myers' bb2121 submission making some 'nervous,' says Mizuho
IBEX Ibex
$10.95 /

+0.7 (+6.83%)

09/11/20 Piper Sandler
Ibex selloff brings valuation 'disconnect,' says Piper Sandler
09/01/20 Truist
Ibex initiated with a Buy at Truist
09/01/20 Baird
Baird starts Ibex with Outperform, sees above industry growth profile
09/01/20 Baird
Ibex initiated with an Outperform at Baird
COST Costco
$347.25 /

+2.67 (+0.77%)

09/04/20 JPMorgan
Costco price target raised to $405 from $365 at JPMorgan
09/03/20 RBC Capital
Costco price target raised to $400 from $381 at RBC Capital
09/03/20 Oppenheimer
Costco price target raised to $400 from $380 at Oppenheimer
09/03/20 Stifel
Costco price target raised to $375 from $360 at Stifel
SAVA Cassava Sciences
$9.72 /

-0.065 (-0.66%)

NVAX Novavax
$102.48 /

+0.92 (+0.91%)

MTN Vail Resorts
$224.35 /

-3.98 (-1.74%)

JRJC China Finance Online
$7.48 /

-0.27 (-3.48%)

IBEX Ibex
$10.95 /

+0.7 (+6.83%)

COST Costco
$347.25 /

+2.67 (+0.77%)

CLNY Colony Capital
$2.34 /

-0.03 (-1.27%)

CAMP CalAmp
$7.90 /

-0.14 (-1.74%)

BMY Bristol-Myers
$58.24 /

-0.76 (-1.29%)

ALT Altimmune
$12.03 /

-0.5 (-3.99%)

AIR AAR Corp.
$17.84 /

+0.36 (+2.06%)

  • 07
    Aug
  • 14
    Jul
NVAX Novavax
$102.48 /

+0.92 (+0.91%)

MTN Vail Resorts
$224.35 /

-3.98 (-1.74%)

COST Costco
$347.25 /

+2.67 (+0.77%)

CLNY Colony Capital
$2.34 /

-0.03 (-1.27%)

BMY Bristol-Myers
$58.24 /

-0.76 (-1.29%)

SAVA Cassava Sciences
$9.72 /

-0.065 (-0.66%)

NVAX Novavax
$102.48 /

+0.92 (+0.91%)

MTN Vail Resorts
$224.35 /

-3.98 (-1.74%)

JRJC China Finance Online
$7.48 /

-0.27 (-3.48%)

IBEX Ibex
$10.95 /

+0.7 (+6.83%)

GNFT Genfit
$3.67 /

-0.28 (-7.09%)

COST Costco
$347.25 /

+2.67 (+0.77%)

CAMP CalAmp
$7.90 /

-0.14 (-1.74%)

BMY Bristol-Myers
$58.24 /

-0.76 (-1.29%)

ALT Altimmune
$12.03 /

-0.5 (-3.99%)

SAVA Cassava Sciences
$9.72 /

-0.065 (-0.66%)

NVAX Novavax
$102.48 /

+0.92 (+0.91%)

MTN Vail Resorts
$224.35 /

-3.98 (-1.74%)

JRJC China Finance Online
$7.48 /

-0.27 (-3.48%)

COST Costco
$347.25 /

+2.67 (+0.77%)

CAMP CalAmp
$7.90 /

-0.14 (-1.74%)

BMY Bristol-Myers
$58.24 /

-0.76 (-1.29%)

ALT Altimmune
$12.03 /

-0.5 (-3.99%)

Earnings
China Finance Online reports Q2 EPS (65c) vs. ($1.29) last year » 18:43
09/24/20
09/24
18:43
09/24/20
18:43
JRJC

China Finance Online

$7.48 /

-0.27 (-3.48%)

Reports Q2 revenue $9.7M…

Reports Q2 revenue $9.7M vs. $8.9M last year. Q2 gross margin increased to 63.3% from 63.1% last year. CEO Zhiwei Zhao says: "During the second quarter of 2020, the Chinese economy and stock markets staged a strong comeback as the pandemic was mostly contained. As a result of improved market sentiment along with our more effective new marketing programs and extensive products and services provisions, our financial information and advisory business experienced a solid rebound. We further reduced our bottom line loss in the second quarter as our diversified offerings, especially in the personal wealth management category, continued to gain traction, and our ongoing cost control proved to be effective. In the post-COVID era, businesses in China, big and small, are facing unprecedented uncertainties that present both challenges and opportunities. As a professional financial media, we have continued to introduce more innovative marketing strategies that leverage our advantages in media resources and capital market services experience to not only promote more transparent and long-term sustainable development of Chinese capital markets, but also help position publicly listed companies to increase their exposure among investment community and deliver a well-crafted message to investors in this post-COVID era. In September, we successfully hosted two impactful events to bring thought leaders, elite investors and Chinese operators in healthcare and real estate sectors to discuss growth trends and investment opportunities. Our mission remains to help operators share best practices, enterprises deliver long-term values and investors identify the best investment ideas. As the Chinese stock market progresses toward maturity, we are also undertaking our social responsibility to promote long-term investment while we continue to grow our investment advisory services for both institutional and retail investor clients."

ShowHide Related Items >><<
JRJC China Finance Online
$7.48 /

-0.27 (-3.48%)

JRJC China Finance Online
$7.48 /

-0.27 (-3.48%)

Hot Stocks
Sanofi CEO: We'll produce over 1B doses of vaccines worldwide for COVID-19 » 18:40
09/24/20
09/24
18:40
09/24/20
18:40
SNY

Sanofi

$50.75 /

+0.15 (+0.30%)

, REGN

Regeneron

$557.69 /

-7.67 (-1.36%)

In an interview on…

In an interview on CNBC's Mad Money, Paul Hudson said he expects a COVID-19 vaccine to be ready by early next year. It won't be in Phase 3 until November or December, he noted. "We're the only company with two COVID-19 vaccines," Hudson said. The company is increasing its flu vaccine by 15%. According to Hudson, Sanofi's (SNY) partnership with Regeneron (REGN) is "high quality." "We are a completely purpose- driven company," he said. "This isn't a race we need to win - everyone needs to play a part."

ShowHide Related Items >><<
SNY Sanofi
$50.75 /

+0.15 (+0.30%)

REGN Regeneron
$557.69 /

-7.67 (-1.36%)

SNY Sanofi
$50.75 /

+0.15 (+0.30%)

09/21/20 Piper Sandler
Regeneron's Libtayo delivered results on par with Keytruda, says Piper Sandler
09/14/20 Roth Capital
Immunic has 'significant' opportunity in RRMS, says Roth Capital
08/24/20 SVB Leerink
SVB Leerink continues to view Alexion as good M&A fit for number of suitors
08/19/20 Stifel
Principia Biopharma downgraded to Hold from Buy at Stifel
REGN Regeneron
$557.69 /

-7.67 (-1.36%)

09/16/20 Canaccord
Eli Lilly COVID-19 data bodes well for Regeneron, says Canaccord
09/16/20 Goldman Sachs
Eli Lilly COVID-19 antibody data 'encouraging,' says Goldman Sachs
09/10/20 Benchmark
Vaccine may be approved before Regeneron's COVID therapeutic, says Benchmark
SNY Sanofi
$50.75 /

+0.15 (+0.30%)

REGN Regeneron
$557.69 /

-7.67 (-1.36%)

  • 27
    May
SNY Sanofi
$50.75 /

+0.15 (+0.30%)

REGN Regeneron
$557.69 /

-7.67 (-1.36%)

SNY Sanofi
$50.75 /

+0.15 (+0.30%)

REGN Regeneron
$557.69 /

-7.67 (-1.36%)

SNY Sanofi
$50.75 /

+0.15 (+0.30%)

REGN Regeneron
$557.69 /

-7.67 (-1.36%)

Hot Stocks
Elastic's Garrett sells 10,000 ordinary shares » 18:38
09/24/20
09/24
18:38
09/24/20
18:38
ESTC

Elastic

$104.65 /

-0.53 (-0.50%)

In a regulatory filing,…

In a regulatory filing, Elastic senior VP and General Counsel W.H. Baird Garrett disclosed the sale of 10,000 ordinary shares of the company on September 22 at a price of $108.0607 per share.

ShowHide Related Items >><<
ESTC Elastic
$104.65 /

-0.53 (-0.50%)

ESTC Elastic
$104.65 /

-0.53 (-0.50%)

09/24/20 Baird
Elastic initiated with a Neutral at Baird
08/27/20 FBN Securities
Elastic price target raised to $125 from $95 at FBN Securities
08/27/20 Stifel
Elastic price target raised to $125 from $84 at Stifel
08/27/20 Monness Crespi
Elastic price target raised to $142 from $100 at Monness Crespi
ESTC Elastic
$104.65 /

-0.53 (-0.50%)

ESTC Elastic
$104.65 /

-0.53 (-0.50%)

ESTC Elastic
$104.65 /

-0.53 (-0.50%)

Periodicals
Google, DOJ brace for legal battle over market power, Reuters says » 18:18
09/24/20
09/24
18:18
09/24/20
18:18
GOOG

Alphabet

$1,428.38 /

+12.63 (+0.89%)

, GOOGL

Alphabet Class A

$1,422.43 /

+12.9 (+0.92%)

The U.S. Justice…

The U.S. Justice Department is anticipated to file a lawsuit against Google as soon as next week, initiating a long legal slog over whether the company uses its outsized market power unfairly, Reuters' Diane Bartz reports. Reference Link

ShowHide Related Items >><<
GOOGL Alphabet Class A
$1,422.43 /

+12.9 (+0.92%)

GOOG Alphabet
$1,428.38 /

+12.63 (+0.89%)

GOOG Alphabet
$1,428.38 /

+12.63 (+0.89%)

09/24/20 Morgan Stanley
Alphabet price target raised to $1,800 after consumer survey at Morgan Stanley
09/18/20 Morgan Stanley
AES Corp. price target raised to $23.50 from $19 at Morgan Stanley
09/14/20 KeyBanc
Alphabet initiated with an Overweight at KeyBanc
08/25/20 UBS
Alphabet price target raised to $1,970 from $1,600 at UBS
GOOGL Alphabet Class A
$1,422.43 /

+12.9 (+0.92%)

09/15/20
Fly Intel: Top five analyst initiations
09/14/20 KeyBanc
Alphabet initiated with an Overweight at KeyBanc
GOOG Alphabet
$1,428.38 /

+12.63 (+0.89%)

GOOG Alphabet
$1,428.38 /

+12.63 (+0.89%)

GOOG Alphabet
$1,428.38 /

+12.63 (+0.89%)

GOOGL Alphabet Class A
$1,422.43 /

+12.9 (+0.92%)

GOOGL Alphabet Class A
$1,422.43 /

+12.9 (+0.92%)

Hot Stocks
Rockwell Medical announces growth plan for its Ferric Pyrophosphate Citrate » 18:12
09/24/20
09/24
18:12
09/24/20
18:12
RMTI

Rockwell Medical

$1.10 /

-0.095 (-7.95%)

Rockwell Medical…

Rockwell Medical concluded its Management and Key Opinion Leader conference call and webcast to discuss potential novel indications for its ferric pyrophosphate citrate, or FPC, platform. CEO Russell Ellison stated: "Earlier today, Rockwell Medical and independent leading experts laid out the pathway for potential important value creation for the Company through the development of the FPC platform to treat medical conditions with unmet clinical needs outside of the hemodialysis setting. This exciting new development plan for FPC, along with increasing adoption of Triferic for dialysis patients, are evidence of Rockwell Medical's continued focus on our vision - to transform the treatment of iron deficiency and anemia for the millions of people affected worldwide. FPC for the treatment of iron deficiency anemia in home infusion patients is our top development priority, which we view as a tractable clinical development project with relatively low safety risk given our extensive safety database of FPC, and low efficacy risk given our expertise and experience in the use of parenteral iron for the treatment of IDA. We expect to hold a Type C meeting with the FDA in the first quarter of 2021 to discuss the program further... We are well capitalized to fund our existing dialysis business and advance clinical development for a home infusion indication, and we expect opportunities for multiple data read-outs and milestone reports from the home infusion program over the next three years as we advance the program through Phase II clinical proof-of-concept development. In addition, we discussed potentially pursuing an indication for FPC in hospitalized patients with acute heart failure. We believe FPC could be uniquely suited for these patients, based upon a completed mechanistic proof-of-concept study and the immediately bioavailable iron that FPC can deliver to patients during a short hospital stay. We continue to evaluate this opportunity and anticipate holding a Type C meeting with the FDA in the second half of 2021 to discuss the pathway for a potential clinical development program."

ShowHide Related Items >><<
RMTI Rockwell Medical
$1.10 /

-0.095 (-7.95%)

RMTI Rockwell Medical
$1.10 /

-0.095 (-7.95%)

03/27/20 Piper Sandler
Piper Sandler remains buyer of Rockwell Medical after Triferic AVNU approval
02/27/20 Piper Sandler
Piper says Rockwell's triferic update 'encouraging' but 'anti-climactic'
11/11/19 Piper Sandler
Rockwell Medical price target lowered to $6 from $10 at Piper Jaffray
RMTI Rockwell Medical
$1.10 /

-0.095 (-7.95%)

  • 04
    Feb
Hot Stocks
Scorpio Tankers announces purchase of common shares by Scorpio Services » 18:05
09/24/20
09/24
18:05
09/24/20
18:05
STNG

Scorpio Tankers

$10.74 /

+0.005 (+0.05%)

Scorpio Tankers announced…

Scorpio Tankers announced that Scorpio Services Holding Limited, a related party, has purchased 100,000 common shares of the company in the open market at an average price of $10.79 per share. Additionally, the President of the company, Robert Bugbee, has purchased call options on an aggregate of 200,000 common shares (or 2,000 call option contracts) of the company for total consideration of $457,000. The option contracts have a strike price of $12.00 and an expiration of April, 2021.

ShowHide Related Items >><<
STNG Scorpio Tankers
$10.74 /

+0.005 (+0.05%)

STNG Scorpio Tankers
$10.74 /

+0.005 (+0.05%)

07/28/20 Deutsche Bank
Scorpio Tankers price target lowered to $27 from $42 at Deutsche Bank
06/19/20 B. Riley FBR
Scorpio Tankers price target lowered to $45 from $55 at B. Riley FBR
06/04/20 Pareto
Scorpio Tankers downgraded to Hold from Buy at Pareto
06/02/20 Fearnley
Scorpio Tankers downgraded to Sell from Hold at Fearnley
STNG Scorpio Tankers
$10.74 /

+0.005 (+0.05%)

STNG Scorpio Tankers
$10.74 /

+0.005 (+0.05%)

Earnings
Trip.com sees Q3 revenue down 47%-52% y/y, consensus $782.57M » 18:02
09/24/20
09/24
18:02
09/24/20
18:02
TCOM

Trip.com Group

$27.76 /

+0.1 (+0.36%)

As a result of the…

As a result of the continued negative impact due to COVID-19 in the third quarter of 2020, the company expects net revenue to decrease by approximately 47%-52% year-over-year for the third quarter of 2020. This forecast reflects the current and preliminary view based on best information available at the time, which is subject to change.

ShowHide Related Items >><<
TCOM Trip.com Group
$27.76 /

+0.1 (+0.36%)

TCOM Trip.com Group
$27.76 /

+0.1 (+0.36%)

09/15/20
Fly Intel: Top analyst downgrades
09/15/20 Outperform, Neutral, Underperform
Trip.com Group downgraded to Neutral from Buy at ICBC
07/10/20 Citi
Trip.com Group upgraded to Buy from Neutral at Citi
06/10/20 BTIG
Trip.com Group initiated with a Neutral at BTIG
TCOM Trip.com Group
$27.76 /

+0.1 (+0.36%)

TCOM Trip.com Group
$27.76 /

+0.1 (+0.36%)

TCOM Trip.com Group
$27.76 /

+0.1 (+0.36%)

Earnings
Trip.com reports Q2 adjusted loss per ADS (27c), consensus (46c) » 18:01
09/24/20
09/24
18:01
09/24/20
18:01
TCOM

Trip.com Group

$27.76 /

+0.1 (+0.36%)

Reports Q2 revenue $448M,…

Reports Q2 revenue $448M, consensus $343.11M. "In the second quarter of 2020, the global travel industry continued to experience significant impact as a result of the ongoing COVID-19 pandemic. On a promising note, we have seen all of our domestic business lines recover to varying degrees during the quarter," said James Liang, Executive Chairman. "As global efforts intensify in this fight against COVID-19, we are increasingly optimistic that there will be more resumption of travel activity in major markets worldwide."

ShowHide Related Items >><<
TCOM Trip.com Group
$27.76 /

+0.1 (+0.36%)

TCOM Trip.com Group
$27.76 /

+0.1 (+0.36%)

09/15/20
Fly Intel: Top analyst downgrades
09/15/20 Outperform, Neutral, Underperform
Trip.com Group downgraded to Neutral from Buy at ICBC
07/10/20 Citi
Trip.com Group upgraded to Buy from Neutral at Citi
06/10/20 BTIG
Trip.com Group initiated with a Neutral at BTIG
TCOM Trip.com Group
$27.76 /

+0.1 (+0.36%)

TCOM Trip.com Group
$27.76 /

+0.1 (+0.36%)

TCOM Trip.com Group
$27.76 /

+0.1 (+0.36%)

Conference/Events
Galectin Therapeutics to host conference call » 17:59
09/24/20
09/24
17:59
09/24/20
17:59
GALT

Galectin Therapeutics

$2.53 /

-0.04 (-1.56%)

Management discusses the…

Management discusses the Company's NASH-RX clinical trial and introduces its new CEO, Joel Lewis, on a conference call to be held on September 29 at 4 pm. Webcast Link

ShowHide Related Items >><<
GALT Galectin Therapeutics
$2.53 /

-0.04 (-1.56%)

GALT Galectin Therapeutics
$2.53 /

-0.04 (-1.56%)

Hot Stocks
OSI Systems CEO sells 40K shares of common stock » 17:58
09/24/20
09/24
17:58
09/24/20
17:58
OSIS

OSI Systems

$77.22 /

+0.83 (+1.09%)

In a regulatory filing,…

In a regulatory filing, OSI Systems disclosed that its CEO Deepak Chopra sold 40K shares of common stock on September 22nd in a total transaction size of $3.12M. The holding represents about 7% of his total owned.

ShowHide Related Items >><<
OSIS OSI Systems
$77.22 /

+0.83 (+1.09%)

OSIS OSI Systems
$77.22 /

+0.83 (+1.09%)

08/21/20 B. Riley FBR
OSI Systems price target lowered to $94 from $97 at B. Riley FBR
05/01/20 Roth Capital
OSI Systems price target lowered to $102 from $122 at Roth Capital
OSIS OSI Systems
$77.22 /

+0.83 (+1.09%)

OSIS OSI Systems
$77.22 /

+0.83 (+1.09%)

OSIS OSI Systems
$77.22 /

+0.83 (+1.09%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.